Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +8.09M | 99% | $6.04 | +$48.8M |
Sells | 2 | -81.1K | 1% | $6.54 | -$530K |
Net | 0 | +8.01M | 98% | +$48.3M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
GSK plc | 10%+ Owner | $134M | +$38.8M | +40.7% | Sep 27, 2024 |
Ken Takanashi | Director, 10%+ Owner | $14.2M | Aug 12, 2024 | ||
Paul Bolno | President and CEO, Director | $2.08M | -$280K | -11.9% | Aug 21, 2024 |
Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | $459K | Jul 22, 2024 | ||
Chris Francis | SVP, Corporate Development, Head of Emerging Areas | $399K | Feb 5, 2024 | ||
Kyle Moran | Chief Financial Officer | $178K | -$251K | -58.5% | Sep 25, 2024 |
Gregory L. Verdine | Director | $114K | Aug 12, 2024 | ||
Heidi Wagner | Director | $79.9K | Aug 12, 2024 | ||
Mark Corrigan | Director | $79.9K | Aug 12, 2024 | ||
Ra Capital Management, L.P. | Director, 10%+ Owner | $40K | +$10M | Aug 12, 2024 | |
Christian O. Henry | Director | $40K | Aug 12, 2024 | ||
Adrian Rawcliffe | Director | $40K | Aug 12, 2024 | ||
Aik Na Tan | Director | $40K | Aug 12, 2024 | ||
Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | Jul 25, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|